Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Effects of a dulaglutide plus calorie-restricted diet versus a calorie-restricted diet on visceral fat and metabolic profiles in women with polycystic ovary syndrome: a randomized controlled trial
A niche audience, a specific pain point, a message that landed
Restrictions continue to rise for many GIP and GLP-1 medications: In 2025, over 82% of people with insurance plans that offer coverage for Wegovy, Zepbound, and Saxenda will encounter restrictions, like prior authorization or step therapy, that make access difficult
Roughly 32% of tirzepatide-treated participants achieved 25% weight loss, versus 16% in the semaglutide arm
US$ 25.33
US$ 27.81
US$ 21.60
